Home / Recalls / Medical Devices
Biomerieux Inc recalls ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927
Recalled January 11, 2023 · FDA recall Z-0849-2023 · Biomerieux
Hazard
As the temperature and time out of range was exceeded, product performances cannot be guaranteed · FDA Class II
Units
2 units
Sold at
US Nationwide distribution.
Description
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Product
ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927
Manufacturer(s)
Biomerieux Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →